---
_schema: default
id: 88621
date: 2024-12-04
title: >-
    How do glycogen storage diseases affect Inuit populations specifically?
article_title: >-
    How do glycogen storage diseases affect Inuit populations specifically?
date_format: MMM DD, YYYY
post_on_text: Posted on
seo:
  title: QuickTakes | Health Studies
  page_description: >-
    This content discusses the impact of glycogen storage diseases, particularly GSD III, on Inuit populations, focusing on its prevalence, genetic factors, clinical manifestations, and the importance of tailored medical approaches.
  page_keywords: >-
    Glycogen storage diseases, Inuit populations, GSD III, genetic predisposition, Nunavik, Canada, glycogen-debranching enzyme, liver involvement, cardiac muscle, skeletal muscle, AGL gene, homozygous frameshift mutation, metabolic disturbances, hypoglycemia, tailored medical management, dietary interventions, genetic research
author: QuickTakes
question: >-
    How do glycogen storage diseases affect Inuit populations specifically?
answer: >-
    Glycogen storage diseases (GSDs) have been observed to affect Inuit populations, particularly through the diagnosis of Glycogen Storage Disease Type III (GSD III). This rare autosomal recessive disorder results from a deficiency of the glycogen-debranching enzyme, which is essential for the complete degradation of glycogen. Over the last decade, four Inuit children from Nunavik, Canada, have been diagnosed with GSD III, with three confirmed cases and one suspected case. This condition had not been previously documented in this population, highlighting its rarity and the potential for a genetic predisposition within this group.\n\nGSD III is characterized by variable involvement of the liver, cardiac muscle, and skeletal muscle. The most common subtype, GSD IIIa, affects approximately 85% of individuals with the disease and typically presents with both liver and muscle symptoms. The incidence of GSD III in the Inuit population is estimated to be around 1 in 2,500, which suggests a significant prevalence compared to other populations.\n\nGenetic studies have identified a homozygous frameshift mutation in the AGL gene, which is responsible for GSD IIIa. This finding indicates a potential founder effect, where a small population has a higher frequency of a particular genetic mutation due to limited genetic diversity. The clinical manifestations of GSD III include hypoglycemia and other metabolic disturbances, which can significantly impact the health and quality of life of affected individuals.\n\nOverall, the identification of GSD III in Inuit children underscores the importance of genetic research and awareness of metabolic disorders in specific populations, as well as the need for tailored medical management and dietary interventions to address these conditions effectively.
subject: Health Studies
file_name: how-do-glycogen-storage-diseases-affect-inuit-populations-specifically.md
url: /learn/health-studies/questions/how-do-glycogen-storage-diseases-affect-inuit-populations-specifically
score: -1.0
related_article1:
    id: 88629
    title: >-
        What are the potential complications of untreated GLUT1 deficiency syndrome?
    subject: Health Studies
    url: /learn/health-studies/questions/what-are-the-potential-complications-of-untreated-glut1-deficiency-syndrome
related_article2:
    id: 88636
    title: >-
        What are the potential benefits of early diagnosis and intervention in carbohydrate metabolism disorders?
    subject: Health Studies
    url: /learn/health-studies/questions/what-are-the-potential-benefits-of-early-diagnosis-and-intervention-in-carbohydrate-metabolism-disorders
related_article3:
    id: 88611
    title: >-
        What are the most common genetic disorders affecting carbohydrate metabolism?
    subject: Health Studies
    url: /learn/health-studies/questions/what-are-the-most-common-genetic-disorders-affecting-carbohydrate-metabolism
---

&nbsp;